Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00746395 · ClinicalTrials.gov registry record · Phase 4
Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy
A Phase 4 study, sponsored by University of South Alabama.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00746395: Completed Phase 4 study, sponsored by University of South Alabama.
NCT00746395 is a Phase 4 study that has completed, run by University of South Alabama. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00746395, a Phase 4 study, has completed, sponsored by University of South Alabama.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
This investigation is designed to compare lubiprostone and placebo for cleansing and propulsion in preparation for capsule endoscopy.
Interventions
- DRUG Placebo
- DRUG Lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00746395
The ClinicalTrials.gov registry entry for NCT00746395 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Alabama, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00746395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00746395 about?
NCT00746395 is a clinical study titled "Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy". This investigation is designed to compare lubiprostone and placebo for cleansing and propulsion in preparation for capsule endoscopy.
What is the current status of trial NCT00746395?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2008-04. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00746395?
The interventions under investigation include: Placebo (DRUG), Lubiprostone (DRUG).
Who is sponsoring clinical trial NCT00746395?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.